Home/Filings/4/0001638599-17-000159
4//SEC Filing

ALBANY MOLECULAR RESEARCH INC 4

Accession 0001638599-17-000159

CIK 0001065087operating

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:03 PM ET

Size

7.7 KB

Accession

0001638599-17-000159

Insider Transaction Report

Form 4
Period: 2017-02-04
Hagen Steven R
VP Pharmaceutical Dev & Mfg
Transactions
  • Tax Payment

    Common Stock

    2017-02-04$18.52/sh2,291$42,42931,560 total
  • Tax Payment

    Common Stock

    2017-02-04$18.52/sh488$9,03830,408 total
  • Tax Payment

    Common Stock

    2017-02-04$18.52/sh664$12,29730,896 total
Footnotes (1)
  • [F1]Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.

Issuer

ALBANY MOLECULAR RESEARCH INC

CIK 0001065087

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001065087

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:03 PM ET
Size
7.7 KB